Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

CYTOO Sponsors the Motility Subgroup at the Biophysical Society Meeting

Published: Monday, January 28, 2013
Last Updated: Monday, January 28, 2013
Bookmark and Share
CYTOO will attend the Biophysical Society (BPS) 57th Annual Meeting in Philadelphia, Pennsylvania, USA to present its innovative Cell Culture Platform, based on adhesive micropatterns.

After the recent launch of the CYTOOplates Motility, specifically designed to study cell migration for screening applications in both oncology and drug discovery, the company has the great pleasure to sponsor the Motility subgroup.

The Biophysical Society’s subgroups allow members to meet and interact within more focusedCYTOOplates-Motility.gif areas in smaller groups. Subgroups hold scientific symposia and business meetings each year on Saturday preceding the start of the Annual Meeting. The mission of the Motility Subgroup is to understand the basic mechanisms that underlie motility and contractility of biological systems.

CYTOO is delighted to have the opportunity to present the Motility products and their unique characteristics to the subgroup members. To celebrate the first anniversary of the World Cell Race1, CYTOO launched in December the CYTOOplates Motility, the microplate version of the CYTOOchips Motility, a perfect tool for studying cell migration, showing characteristics closer to those found in vivo2.

CYTOO’s Motility products feature adhesive tracks of 4 different widths from 2.5 to 20 μm allowing a wide range of applications including single vs collective cell migration, cell pairing, and in other application areas, such as directional neurite outgrowth assays.

Attendees are invited to visit BPS booth #650 to discover the Motility products, and to discuss their 2D+ application with Alexandra Fuchs, PhD, COO, and Yoran Margaron, PhD, Research Scientist.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,600+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Revealing the Genetic Causes of Bowel Cancer
A landmark study has given the most detailed picture yet of the genetics of bowel cancer — the UK's fourth most common cancer.
Self-Assembling Protein Shell for Drug Delivery
Made-to-order nano-cages open possibilities of shipping cargo into living cells or fashioning small chemical reactors.
Fighting Resistant Blood Cancer Cells
Biologists present new findings on chronic myeloid leukemia and possible therapeutic approaches.
Tumor Cells Develop Predictable Characteristics
Scientists have discovered that cancer cells at the edge of a tumor that are close to the surrounding environment are predictably different from the cells within the interior of the tumor.
Guided Chemotherapy Missiles
Latching chemotherapy drugs onto proteins that seek out tumors could provide a new way of treating tumors in the brain or with limited blood supply that are hard to reach with traditional chemotherapy.
Solutions for Biotherapeutic Characterization
Innovation to speed the routine.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Biomarkers That Could Help Give Cancer Patients Better Survival Estimates Discovered
UCLA research may also help scientists suppress dangerous genetic sequences.
Body’s Own Gene Editing System Generates Leukemia Stem Cells
Inhibiting the editing enzyme may provide a new therapeutic approach for blood cancers.
A New Approach to Chemical Synthesis
Communesins, originally found in fungus, could hold potential as cancer drugs.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,600+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!